Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
7.05
-0.10
(-1.40%)
At close: February 28 at 4:25:36 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-97,130
-97,130
-53,936
-45,048
-29,823
Investing Cash Flow
-8,095
-8,095
-12,026
-6,232
-575
Financing Cash Flow
335,290
335,290
32,211
82,679
49,929
End Cash Position
251,942
251,942
26,950
60,701
29,302
Capital Expenditure
-265
-265
-323
-47
-898
Issuance of Capital Stock
353,387
353,387
46,374
69,683
26,395
Issuance of Debt
55,841
55,841
--
24,913
26,948
Repayment of Debt
-40,602
-40,602
-9,711
-5,786
-3,414
Free Cash Flow
-97,395
-97,395
-54,259
-45,095
-30,721
12/31/2020 - 11/7/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
25I.F ImmuPharma plc
0.0265
-37.65%
SANNz.XC
0EVI.IL Innate Pharma S.A.
2.1375
-3.93%
VTRO
KAPA Kairos Pharma, Ltd.
1.1900
-1.65%
AFMD Affimed N.V.
1.0300
-0.96%
MBX MBX Biosciences, Inc.
9.60
-2.24%
ZBIO Zenas BioPharma, Inc.
7.01
+6.05%
BCAX Bicara Therapeutics Inc.
13.30
+7.61%
CSBR Champions Oncology, Inc.
10.28
+0.59%